Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Qian

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Plos Neglected Tropical Diseases|August 2, 2016
Spatiotemporal Dynamics of Scrub Typhus Transmission in Mainland China, 2006-2014Yi-Cheng Wu, Quan Qian, Ricardo J Soares Magalhaes, et al.
Microbiome|June 6, 2024
Compendium of 5810 genomes of sheep and goat gut microbiomes provides new insights into the glycan and mucin utilizationKe Zhang, Chong He, Lei Wang, et al.
European Journal of Pharmacology|December 14, 2011
INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functionsNiu Shin, Maryanne Covington, Di Bian, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune DiseasesJincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry|January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWenqing Yao, Jincong Zhuo, David M Burns, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Plos Neglected Tropical Diseases|August 2, 2016
Spatiotemporal Dynamics of Scrub Typhus Transmission in Mainland China, 2006-2014Yi-Cheng Wu, Quan Qian, Ricardo J Soares Magalhaes, et al.
Microbiome|June 6, 2024
Compendium of 5810 genomes of sheep and goat gut microbiomes provides new insights into the glycan and mucin utilizationKe Zhang, Chong He, Lei Wang, et al.
European Journal of Pharmacology|December 14, 2011
INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functionsNiu Shin, Maryanne Covington, Di Bian, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune DiseasesJincong Zhuo, Yun-Long Li, Ding-Quan Qian, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Journal of Medicinal Chemistry|January 30, 2007
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWenqing Yao, Jincong Zhuo, David M Burns, et al.
Pageof 6